Federowicz , I. (2012). Phase III clinical trial evaluating the use pazopanib in the treatment of kidney cancer - a discussion assumptions and results of the study. OncoReview, 2(1(5), 65-68. Retrieved from https://journalsmededu.pl/index.php/OncoReview/article/view/298